Rhumbline Advisers Boosts Stock Position in CG Oncology, Inc. (NASDAQ:CGON)
Rhumbline Advisers increased its position in shares of CG Oncology, Inc. (NASDAQ:CGON – Free Report) by 2.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 69,016 shares of the company’s stock after acquiring an additional 1,458 shares during the quarter. Rhumbline Advisers’ […]
Rhumbline Advisers increased its position in shares of CG Oncology, Inc. (NASDAQ:CGON – Free Report) by 2.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 69,016 shares of the company’s stock after acquiring an additional 1,458 shares during the quarter. Rhumbline Advisers’ […]
